JP2010536043A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536043A5
JP2010536043A5 JP2010520409A JP2010520409A JP2010536043A5 JP 2010536043 A5 JP2010536043 A5 JP 2010536043A5 JP 2010520409 A JP2010520409 A JP 2010520409A JP 2010520409 A JP2010520409 A JP 2010520409A JP 2010536043 A5 JP2010536043 A5 JP 2010536043A5
Authority
JP
Japan
Prior art keywords
gelsolin
polypeptide
subject
level
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010520409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536043A (ja
Filing date
Publication date
Priority claimed from PCT/CN2007/002467 external-priority patent/WO2009021360A1/en
Application filed filed Critical
Publication of JP2010536043A publication Critical patent/JP2010536043A/ja
Publication of JP2010536043A5 publication Critical patent/JP2010536043A5/ja
Pending legal-status Critical Current

Links

JP2010520409A 2007-08-15 2008-08-15 尿ゲルゾリンの検出および定量化 Pending JP2010536043A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2007/002467 WO2009021360A1 (en) 2007-08-15 2007-08-15 Gelsolin binding agent compositions and uses of same
PCT/CN2008/072005 WO2009024070A1 (en) 2007-08-15 2008-08-15 Detection and quantitation of urine gelsolin

Publications (2)

Publication Number Publication Date
JP2010536043A JP2010536043A (ja) 2010-11-25
JP2010536043A5 true JP2010536043A5 (enExample) 2011-03-24

Family

ID=40350342

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010520397A Pending JP2010537625A (ja) 2007-08-15 2007-08-15 ゲルゾリン結合剤組成物およびその使用
JP2010520409A Pending JP2010536043A (ja) 2007-08-15 2008-08-15 尿ゲルゾリンの検出および定量化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010520397A Pending JP2010537625A (ja) 2007-08-15 2007-08-15 ゲルゾリン結合剤組成物およびその使用

Country Status (5)

Country Link
US (2) US8367356B2 (enExample)
EP (2) EP2188309A4 (enExample)
JP (2) JP2010537625A (enExample)
CN (2) CN102119173B (enExample)
WO (2) WO2009021360A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2535718B1 (en) 2007-05-11 2014-07-09 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
CN102119173B (zh) * 2007-08-15 2015-04-08 北京同为时代生物技术有限公司 凝溶胶蛋白结合剂组合物及其用途
US20100136610A1 (en) * 2008-12-03 2010-06-03 Jeong-Yeol Yoon Methods And Microfluidic Devices For Single Cell Detection Of Escherichia Coli
US9562855B1 (en) 2009-12-03 2017-02-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Devices and methods for detection of microorganisms via MIE scattering
US9678005B1 (en) 2008-12-03 2017-06-13 Arizona Board Of Regents On Behalf Of The University Of Arizona Devices and methods for detection of microorganisms
EP2725360A1 (en) * 2012-10-24 2014-04-30 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Biomarkers for the prognosis of ischemic stroke
WO2016054383A1 (en) * 2014-10-01 2016-04-07 Henry Ford Health System Methods for treating sepsis and biomarkers related thereto
FR3036188B1 (fr) * 2015-05-12 2019-06-07 Biomerieux Prediction du risque de developper, pour des patients admis en service de reanimation, une infection disseminee
CN108020663A (zh) * 2016-11-02 2018-05-11 张曼 尿液凝溶胶蛋白及其多肽片段在肺腺癌中的应用
US10905585B1 (en) 2020-02-21 2021-02-02 Robert Sabin Respiratory therapeutic electric heat source face mask
AU2021268600A1 (en) * 2020-05-04 2022-12-08 Bioaegis Therapeutics Inc. Compositions comprising gelsolin for treating frailty
US20230357388A1 (en) * 2020-09-25 2023-11-09 The Francis Crick Institute Limited Immunotherapy
CN115308010B (zh) * 2021-05-06 2025-05-23 威高集团有限公司 一种抗体保护剂和采血管
WO2024087613A1 (zh) 2022-10-24 2024-05-02 浙江宇龙药业有限公司 一种含七氟异丙基的双酰胺类化合物及其中间体化合物,其制备方法与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650487A (en) 1988-09-09 1997-07-22 The Regents Of The University Of California Serum immunoregulatory polypeptides and uses therefor
WO1994003601A2 (en) 1992-08-03 1994-02-17 New York University Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
JP3914272B2 (ja) * 1993-12-28 2007-05-16 中外製薬株式会社 アドゼベリンをコードする遺伝子
WO2005014635A2 (en) 2003-07-15 2005-02-17 Genova Ltd. Secreted polypeptide species reduced in cardiovascular disorders
ES2848385T3 (es) * 2003-11-12 2021-08-09 Univ Pennsylvania Métodos de uso de gelsolina para tratar o prevenir septicemia bacteriana
CN1746676A (zh) * 2004-09-08 2006-03-15 中国医学科学院肿瘤医院肿瘤研究所 一种胰腺癌血清标志分子的检测方法
WO2006091861A2 (en) 2005-02-25 2006-08-31 Ppd Biomarker Discovery Sciences, Llc Compositions and methods relating to cns lymphoma
AU2007227613A1 (en) * 2006-03-15 2007-09-27 The Brigham And Women's Hospital, Inc. Use of gelsolin to diagnose and treat inflammatory diseases
WO2007137582A1 (en) 2006-05-30 2007-12-06 Antibodyshop A/S Methods and devices for rapid assessment of severity of injury and disease
CN102119173B (zh) * 2007-08-15 2015-04-08 北京同为时代生物技术有限公司 凝溶胶蛋白结合剂组合物及其用途

Similar Documents

Publication Publication Date Title
JP2010536043A5 (enExample)
JP2006502416A5 (enExample)
JP2007525427A5 (enExample)
JP2014524744A5 (enExample)
JP2011507810A5 (enExample)
JP2007535470A5 (enExample)
US10114028B2 (en) Biomarkers for pneumonia and acute decompensated heart failure
RU2014104113A (ru) Elisa для vegf
JP2016505634A5 (enExample)
HRP20180353T1 (hr) Protutijela protiv folatnog receptora alfa i njihova upotreba
RU2008139098A (ru) Способы диагностики рака поджелудочной железы с применением белка reg4
TR201806292T4 (tr) Prokalsi̇toni̇ni̇n saptanmasi i̇çi̇n i̇mmünoloji̇k test
JP2012524521A5 (enExample)
JP2007506945A5 (enExample)
JP2019531716A5 (enExample)
JP2014518624A5 (enExample)
JP2017531801A5 (enExample)
JP2018527895A5 (enExample)
Nencini et al. Assays and strategies for immunogenicity assessment of biological agents
JPWO2008035527A1 (ja) 抗C1qモノクローナル抗体
JP2015514707A5 (enExample)
JP2013506837A5 (enExample)
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
JP2008532931A5 (enExample)
FI3356826T3 (fi) Gdf-15 melanooman diagnostisena markkerina